Jaguar Health, Inc. (JAGX) financial statements and ratios from SEC XBRL: revenue $11.51M (TTM), net margin -465.4%, revenue growth -58.9% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $11.51M |
| Net Margin | -465.4% |
| Return on Equity | -747.5% |
| Current Ratio | 0.69 |
| Revenue Growth (YoY) | -58.9% |
| EPS Growth (YoY) | 53.0% |
| Altman Z-Score | -18.88 (distress) |
| Sector P/E (Healthcare) | 21.7 |
JAGX overview · JAGX earnings · JAGX KPIs · JAGX investor relations · JAGX ownership · JAGX peers · JAGX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.